| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.6 |